Description

Summary

Based on product types,the psoriasis drugs segment dominated the global market prescription dermatology therapeutics in 2017.

In 2017, the global Prescription Dermatology Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2018 and 2025.

This report studies the Prescription Dermatology Therapeutics market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

This report focuses on the global top players, covered

Pfizer

AbbVie

Johnson & Johnson

Novartis

Amgen

Eli Lilly

Celgene

LEO Pharma

Bausch Health Companies

Sun Pharmaceutical

Aclaris Therapeutics

Market segment by Regions/Countries, this report covers

North America

Europe

China

Rest of Asia Pacific

Central & South America

Middle East & Africa

Market segment by Type, the product can be split into

Fungal Infection Drugs

Skin Cancer Drugs

Acne & Rosacea Drugs

Psoriasis Drugs

Dermatitis & Seborrhea Drugs

Market segment by Application, the market can be split into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The study objectives of this report are:

To study and forecast the market size of Prescription Dermatology Therapeutics in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast among global major regions.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Prescription Dermatology Therapeutics are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:

Further breakdown of Prescription Dermatology Therapeutics market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.


Research Methodology

QY Reports in their recently published report, have emphasized upon the unique and key findings of the industry for a particular assessment period. The report mainly categorizes the custom market survey conducted by the experts to collect high-quality data analysis and visualization to bring out the various dynamics of the industry. It offers a detailed information about the latest updates such as several new technological advancements made, mergers and acquisitions, new entrants in the market, which make an impact on different segments of the industry.

Segmental Analysis

The global industry has been segmented on the basis of its products, regions, end users, technology, applications and cues for positioning, advertising & communication strategies. For a better understanding of the market, QY Reports has also provided a detailed analysis of drivers, restraints, and opportunities that dominate the present market scenario and also provides the anticipation of the future status of this industry.

QY Reports emphasizes on the essentials of analyzing qualitative and quantitative aspects of the industry. While giving a brief idea about the revenue opportunities for all the segments, this report has also provided the impact of industry expertise to determine the scope of the study for all the segments over the predicted period.

Regional Analysis

The report comprises of the geographical landscape of the industry and is briefly segmented into key regions such as North America, the Asia Pacific, Latin America, and the Middle East and Africa. Our research methodology also focuses on understanding the niche countries such as Vietnam, Indonesia, Thailand, Malaysia, Mexico, and Italy to give lucid essence of the country-wide acceptance and growth of this industry. It also provides the reader with extensive data related to the market thus, empowering them to make informed decisions about doing business.

Our infallible research methodology offers flexibility to suit varying budgets, deadlines, and altering market dynamics. Our researches cover a detailed comprehension of a wide spectrum of products and services, along with the business strategies adopted by the new entrants who are trying to establish themselves in the competitive landscape. The market size and revenue generated by each segments has been analyzed with the help of Basis Point Share technique, which accurately calculates the percentage change in the value of trending products.

QY Reports is committed to offer a targeted market view in order to eliminate redundant information for the complete satisfaction of thereader.

Various sales channels such as Original Equipment Manufacturers and aftermarkets across various key regions are covered in this report.

Our quantitative research approach identifies the market size and how much it might be worth to find areas for sales growth. It also helps the reader understand the demographics of customers, such as their gender and age. The qualitative research renders a better understanding of the customer requirements and identifies opportunities for enhancing sales and also improving customer service.

Our research experts have focused on to offer a detailed description of the supply side of the business before placing the product in the market. The syndicated research covers critical aspects of market research to generate useful strategies that ensure accurate analysis, high-level data integrity, and impeccable forecasts. On-demand customization or bespoke proposals are rendered to exactly meet the customer needs. The information provided regarding the geographical segmentation and the competitive landscape is based on the study done on the authenticated data from direct observations, online surveys, government agencies, industry bodies, and expert interviews.

QY Reports offers market attractiveness, which presents a market index to help the clients and target audiences recognize the numerous opportunities that the industry holds.

In order to authenticate the data, our experts have interviewed the industry experts on various panels across the globe who have sufficient experience and knowledge related to the field. QY Reports has used frameworks such as Year on Year growth forecast, parent market overview for data analysis, and the performance of various macroeconomic factors. Also, the analysts have gathered all the necessary information from the annual reports of various companies, their official websites, and some paid publications in order to offer full-proof reports to our clients.

The report has developed a time-bound strategic roadmap for the readers by weaving different aspects of business into a winning fabric.


Table of Contents
Prescription Dermatology Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025

1 Industry Overview of Prescription Dermatology Therapeutics

1.1 Prescription Dermatology Therapeutics Market Overview

1.1.1 Prescription Dermatology Therapeutics Product Scope

1.1.2 Market Status and Outlook

1.2 Global Prescription Dermatology Therapeutics Market Size and Analysis by Regions

1.2.1 North America

1.2.2 Europe

1.2.3 China

1.2.4 Rest of Asia Pacific

1.2.5 Central & South America

1.2.6 Middle East & Africa

1.3 Prescription Dermatology Therapeutics Market by Type

1.3.1 Fungal Infection Drugs

1.3.2 Skin Cancer Drugs

1.3.3 Acne & Rosacea Drugs

1.3.4 Psoriasis Drugs

1.3.5 Dermatitis & Seborrhea Drugs

1.4 Prescription Dermatology Therapeutics Market by End Users/Application

1.4.1 Hospital Pharmacies

1.4.2 Retail Pharmacies

1.4.3 Online Pharmacies

2 Global Prescription Dermatology Therapeutics Competition Analysis by Players

2.1 Prescription Dermatology Therapeutics Market Size (Value) by Players (2017 and 2018)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 Pfizer

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.1.5 Recent Developments

3.2 AbbVie

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.2.5 Recent Developments

3.3 Johnson & Johnson

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.3.5 Recent Developments

3.4 Novartis

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.4.5 Recent Developments

3.5 Amgen

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.5.5 Recent Developments

3.6 Eli Lilly

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.6.5 Recent Developments

3.7 Celgene

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.7.5 Recent Developments

3.8 LEO Pharma

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.8.5 Recent Developments

3.9 Bausch Health Companies

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.9.5 Recent Developments

3.10 Sun Pharmaceutical

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Prescription Dermatology Therapeutics Revenue (Value) (2013-2018)

3.10.5 Recent Developments

3.11 Aclaris Therapeutics

4 Global Prescription Dermatology Therapeutics Market Size by Type and Application (2013-2018)

4.1 Global Prescription Dermatology Therapeutics Market Size by Type (2013-2018)

4.2 Global Prescription Dermatology Therapeutics Market Size by Application (2013-2018)

4.3 Potential Application of Prescription Dermatology Therapeutics in Future

4.4 Top Consumer/End Users of Prescription Dermatology Therapeutics

5 North America Prescription Dermatology Therapeutics Development Status and Outlook

5.1 North America Prescription Dermatology Therapeutics Market Size (2013-2018)

5.2 North America Prescription Dermatology Therapeutics Market Size and Market Share by Players (2017 and 2018)

6 Europe Prescription Dermatology Therapeutics Development Status and Outlook

6.1 Europe Prescription Dermatology Therapeutics Market Size (2013-2018)

6.2 Europe Prescription Dermatology Therapeutics Market Size and Market Share by Players (2017 and 2018)

7 China Prescription Dermatology Therapeutics Development Status and Outlook

7.1 China Prescription Dermatology Therapeutics Market Size (2013-2018)

7.2 China Prescription Dermatology Therapeutics Market Size and Market Share by Players (2017 and 2018)

8 Rest of Asia Pacific Prescription Dermatology Therapeutics Development Status and Outlook

8.1 Rest of Asia Pacific Prescription Dermatology Therapeutics Market Size (2013-2018)

8.2 Rest of Asia Pacific Prescription Dermatology Therapeutics Market Size and Market Share by Players (2017 and 2018)

9 Central & South America Prescription Dermatology Therapeutics Development Status and Outlook

9.1 Central & South America Prescription Dermatology Therapeutics Market Size (2013-2018)

9.2 Central & South America Prescription Dermatology Therapeutics Market Size and Market Share by Players (2017 and 2018)

10 Middle East & Africa Prescription Dermatology Therapeutics Development Status and Outlook

10.1 Middle East & Africa Prescription Dermatology Therapeutics Market Size (2013-2018)

10.2 Middle East & Africa Prescription Dermatology Therapeutics Market Size and Market Share by Players (2017 and 2018)

11 Market Forecast by Regions, Type and Application (2018-2025)

11.1 Global Prescription Dermatology Therapeutics Market Size (Value) by Regions (2018-2025)

11.1.1 North America Prescription Dermatology Therapeutics Revenue and Growth Rate (2018-2025)

11.1.2 Europe Prescription Dermatology Therapeutics Revenue and Growth Rate (2018-2025)

11.1.3 China Prescription Dermatology Therapeutics Revenue and Growth Rate (2018-2025)

11.1.4 Rest of Asia Pacific Prescription Dermatology Therapeutics Revenue and Growth Rate (2018-2025)

11.1.5 Central & South America Prescription Dermatology Therapeutics Revenue and Growth Rate (2018-2025)

11.1.6 Middle East & Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2018-2025)

11.2 Global Prescription Dermatology Therapeutics Market Size (Value) by Type (2018-2025)

11.3 Global Prescription Dermatology Therapeutics Market Size by Application (2018-2025)

12 Prescription Dermatology Therapeutics Market Dynamics

12.1 Prescription Dermatology Therapeutics Market Opportunities

12.2 Prescription Dermatology Therapeutics Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Prescription Dermatology Therapeutics Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Prescription Dermatology Therapeutics Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source